Status:
COMPLETED
Observational Registry for Basal Insulin Treatment Study (ORBIT)
Lead Sponsor:
The George Institute for Global Health, China
Collaborating Sponsors:
Chinese Diabetes Society
Conditions:
Diabetes
Eligibility:
All Genders
18-80 years
Brief Summary
The scientific use of basal insulin is of great help to individuals and the government. However, there are few studies to investigate the real world use, effect, safety and influence factors of basal ...
Detailed Description
This is a 6-month multicentre, observational, prospective, registry study. About 200 hospitals from different parts of China will take part in this study, and about 20,000 patients with type 2 diabete...
Eligibility Criteria
Inclusion
- 18-80 years old
- Type 2 diabetic patients
- Taking OADs before inclusion
- Recently tested HbA1c \>=7% at the same site within 3 months
- Being suggested by physician to start basal insulin (BI) treatment
- Willing to start and having been prescribed BI treatment
- Willing to join the registry study and sign the informed consent
Exclusion
- Diagnosed with type 1 diabetes
- Received any type of insulin in the last 2 years (except for the intermittent use of insulin of less than 1 month each time)
- With any severe health problem, or any other situation judged by the investigator, that is difficult for the 6 months follow-up
- Current or planned pregnant, lactating women
- Involved in other clinical trial simultaneously or at most 1 month before
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
19894 Patients enrolled
Trial Details
Trial ID
NCT01859598
Start Date
December 1 2011
End Date
June 1 2014
Last Update
October 12 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Haidian hospital
Beijing, Beijing Municipality, China
2
Peking University People's Hospital
Beijing, Beijing Municipality, China